Indivior (NASDAQ:INDV) stock is falling on Tuesday as investors have concerns following a business update from the pharmaceutical company.
The big news here is Indivior updating its Q2 outlook. That includes Q2 revenue guidance ranging from $295 million to $303 million. That doesn’t look good next to Wall Street’s estimate of $301.65 million.
Indivior’s updated its 2024 guidance at the same time. The company is lowering its outlook alongside a combination of transitory factors. Included in this is the end of COVID-19 emergency measures.
https://investorplace.com/2024/07/why-is-indivior-indv-stock-down-37-today/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.